Thus, our findings regarding Kv1.1 modulation of early postnatal neurogenesis may help lay the groundwork for future identification of novel therapeutic targets for neurodegenerative and psychiatric diseases (Christian et al., 2014). This evidence concerns the gene KCNA1 and psychiatric disorder.